Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
29.07
-0.45 (-1.52%)
Mar 6, 2026, 9:52 AM EST - Market open
Rigel Pharmaceuticals Employees
As of December 31, 2024, Rigel Pharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,794,402
Profits / Employee
$2,237,951
Market Cap
537.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Vor Biopharma | 154 |
| Alpha Tau Medical | 125 |
| Ocugen | 95 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
| Zura Bio | 30 |
RIGL News
- 2 days ago - Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 10 days ago - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - PRNewsWire
- 4 weeks ago - Rigel Appoints Michael P. Miller to the Board of Directors - PRNewsWire
- 5 weeks ago - Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 - Seeking Alpha
- 7 weeks ago - Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Rigel Provides Business Update and 2026 Outlook - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire